.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Harvard Business School
US Army
Moodys
Farmers Insurance
McKinsey
Colorcon
Cipla
McKesson
Teva

Generated: September 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021673

« Back to Dashboard
NDA 021673 describes CLOLAR, which is a drug marketed by Genzyme and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug and one Paragraph IV challenge. Additional details are available on the CLOLAR profile page.

The generic ingredient in CLOLAR is clofarabine. There are eleven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the clofarabine profile page.

Summary for NDA: 021673

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1

Pharmacology for NDA: 021673

Suppliers and Packaging for NDA: 021673

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLOLAR
clofarabine
INJECTABLE;IV (INFUSION) 021673 NDA sanofi-aventis U.S. LLC 0024-5860 0024-5860-01 1 VIAL, SINGLE-USE in 1 BOX (0024-5860-01) > 20 mL in 1 VIAL, SINGLE-USE
CLOLAR
clofarabine
INJECTABLE;IV (INFUSION) 021673 NDA sanofi-aventis U.S. LLC 0024-5917 0024-5917-01 1 VIAL, SINGLE-USE in 1 BOX (0024-5917-01) > 20 mL in 1 VIAL, SINGLE-USE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;IV (INFUSION)Strength20MG/20ML (1MG/ML)
Approval Date:Dec 28, 2004TE:APRLD:Yes
Patent:► SubscribePatent Expiration:Jul 14, 2018Product Flag?Substance Flag?Delist Request?Y

Expired Orange Book Patents for NDA: 021673

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Genzyme
CLOLAR
clofarabine
INJECTABLE;IV (INFUSION)021673-001Dec 28, 2004► Subscribe► Subscribe
Genzyme
CLOLAR
clofarabine
INJECTABLE;IV (INFUSION)021673-001Dec 28, 2004► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Healthtrust
QuintilesIMS
Argus Health
Julphar
Baxter
Mallinckrodt
Cipla
Chinese Patent Office
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot